Bioactive Lipids in Cancer, Inflammation and Related Diseases



Dear Colleagues:

This has been an extraordinarily difficult year, marked by near-constant uncertainty, thrusting us into unchartered territory with hardship and adaption to new ways of teaching, learning and conducting research without sacrificing our commitment to excellence. The Covid-19 pandemic has played a critical role not only in the surging death rates but has delayed cancer and other disease diagnosis and treatment, while increasing mortality.

As Covid vaccines are administered world-wide, and herd immunity is imminent, we are turning a corner and look forward to the long awaited in-person scientific meetings to commence allowing us to network with colleagues, face to face.

The 17th International Bioactive Lipids Conference will be held in New Orleans, Louisiana on Oct. 30 – Nov. 2, 2022.

We are thrilled and honored to announce that Robert J. Lefkowitz, M.D. will serve as the Keynote Speaker. Dr. Lefkowitz is the recipient of the Nobel Prize in Chemistry in 2012 for studies of G-protein-coupled receptors and recently wrote an engaging and energetic memoir titled A Funny Thing Happened on the Way to Stockholm, which I can attest is an enjoyable read. 

I am proud that this conference continues to be the premier lipid meeting series. The Eicosanoid Research Foundation has a dedicated Board of Directors committed to ensuring that the science presented is comprehensive and structured to highlight cutting edge research on the role of lipid mediators in various physiological and pathological processes in a wide range of therapeutic areas. The scientific program is comprised of 50% Invited Speakers and 50% oral presentations chosen from abstract submissions.

Equally as important, this forum provides a platform for young investigators, postdoctoral fellows and graduate students to present their work, interact with internationally renowned investigators and further their scientific careers and professional development. Announcements will be forthcoming regarding the many Travel Award opportunities and Achievement Award competitions for young investigators, graduate students and trainees.

I invite you to continue the time-honored tradition of supporting and mentoring the careers of young scientists by encouraging those at your institution to submit an abstract, apply for a travel award and/or achievement award, and participate in what promises to be another outstanding conference in this series.

Kenneth V. Honn, Ph.D.
President, Eicosanoid Research Foundation
Distinguished Professor of Pathology, Oncology and Chemistry
Wayne State University

Subscribe to our Mailing List